Dr. M. Lia Palomba

Dr. M. Lia Palomba, MD, is a hematologist-oncologist specializing in the diagnosis and treatment of lymphoma, with a particular focus on B cell malignancies. Her clinical expertise spans a wide range of lymphoid cancers, including indolent lymphomas such as follicular, marginal zone, and small lymphocytic lymphoma, as well as Waldenström's macroglobulinemia, chronic lymphocytic leukemia, and aggressive diseases like diffuse large B cell lymphoma. Through her work at a leading cancer center, she provides specialized care for patients facing both newly diagnosed and relapsed or refractory lymphomas.

Dr. Palomba's research is centered on tumor immunology and the development of novel therapies that harness the immune system to fight cancer. She serves as head of hematological malignancies for the Cellular Therapeutics Center, where she has played a fundamental role in the development and implementation of CAR T cell therapy. Her work also encompasses targeted therapies for lymphoma, with a strong interest in understanding the mechanisms by which these treatments exert their effects. Through her dual focus on immunotherapy and targeted agents, she has contributed meaningfully to advancing treatment options for patients with both indolent and aggressive B cell lymphomas.

In addition to her clinical and laboratory research, Dr. Palomba is an active member of the Waldenström's Macroglobulinemia Clinical Trial Group, reflecting her commitment to advancing care for patients with this rare and complex disease through collaborative, multicenter investigation. Her work across clinical trials and translational research continues to shape emerging standards of care for patients with lymphoid malignancies.